StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.67−0.23 (-12.08%)

Close on Nov 17, 2026Market cap $1.37MP/E –Yield –

Genprex operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Genprex's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.56M. For fiscal 2025 it was -$15.31M. The highest annual figure on record is -$1.25M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.31M–
FY2024Dec 31, 2024-$17.92M–
FY2023Dec 31, 2023-$24.74M–
FY2022Dec 31, 2022-$17.62M–
FY2021Dec 31, 2021-$14.28M–
FY2020Dec 31, 2020-$13.94M–
FY2019Dec 31, 2019-$6.92M–
FY2018Dec 31, 2018-$6.85M–
FY2017Dec 31, 2017-$2.17M–
FY2016Dec 31, 2016-$1.25M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.14M–
Q1 FY2026Mar 31, 2026-$3.14M–
Q4 FY2025Dec 31, 2025-$4.10M–
Q3 FY2025Sep 30, 2025-$3.19M–
Q2 FY2025Jun 30, 2025-$3.86M–
Q1 FY2025Mar 31, 2025-$4.16M–
Q4 FY2024Dec 31, 2024-$3.87M–
Q3 FY2024Sep 30, 2024-$2.19M–
Q2 FY2024Jun 30, 2024-$6.57M–
Q1 FY2024Mar 31, 2024-$5.30M–
Q4 FY2023Dec 31, 2023-$4.96M–
Q3 FY2023Sep 30, 2023-$4.74M–
Q2 FY2023Jun 30, 2023-$8.11M–
Q1 FY2023Mar 31, 2023-$6.93M–
Q4 FY2022Dec 31, 2022-$4.55M–
Q3 FY2022Sep 30, 2022-$4.52M–
Q2 FY2022Jun 30, 2022-$4.48M–
Q1 FY2022Mar 31, 2022-$4.07M–
Q4 FY2021Dec 31, 2021-$3.22M–
Q3 FY2021Sep 30, 2021-$2.63M–
Q2 FY2021Jun 30, 2021-$2.97M–
Q1 FY2021Mar 31, 2021-$5.47M–
Q4 FY2020Dec 31, 2020-$3.89M–
Q3 FY2020Sep 30, 2020-$2.02M–
Q2 FY2020Jun 30, 2020-$3.51M–
Q1 FY2020Mar 31, 2020-$4.52M–
Q4 FY2019Dec 31, 2019-$1.72M–
Q3 FY2019Sep 30, 2019-$1.99M–
Q2 FY2019Jun 30, 2019-$1.57M–
Q1 FY2019Mar 31, 2019-$1.64M–
Q4 FY2018Dec 31, 2018-$2.06M–
Q3 FY2018Sep 30, 2018-$1.47M–
Q2 FY2018Jun 30, 2018-$3.11M–
Q1 FY2018Mar 31, 2018-$203.71K–
Q4 FY2017Dec 31, 2017-$211.57K–
Q3 FY2017Sep 30, 2017-$638.94K–
Q2 FY2017Jun 30, 2017-$671.78K–
Q1 FY2017Mar 31, 2017-$649.31K–
Q4 FY2016Dec 31, 2016-$848.64K–

More Genprex figures

See a number that looks wrong?